Sign In
Buy LLY
$1,131.42
+6.04 (+0.537%)
At Close: Jun 05, 2026
Concerns Over Muscle Loss with GLP-1 Weight Loss Drugs (LLY, NVO, REGN)
02:10am, Monday, 07'th Oct 2024
Clinical studies highlight that Eli Lilly (LLY, Financial) and Novo Nordisk's (NVO) weight loss drugs result in significant lean body mass reduction, with 25% and 40% of weight loss attributed to musc
Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades
04:45am, Saturday, 05'th Oct 2024
Investors can find market-trouncing blue chip stocks in the healthcare industry.
Eli Lilly (LLY) Rises But Trails Market: What Investors Should Know
06:51pm, Friday, 04'th Oct 2024
Eli Lilly (LLY) concluded the recent trading session at $887.16, signifying a +0.18% move from its prior day's close.
Hims & Hers Health Asserts Demand For Its Compounded Weight Loss Offering To Continue Despite Resolved Supply Shortages
02:21pm, Friday, 04'th Oct 2024
Thursday, The FDA determined the shortage of Eli Lilly And Co's LLY tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, has been resolved.
The Big 3: LLY, CVX, RBLX
12:06pm, Friday, 04'th Oct 2024
Today's Big 3 dives into medical, energy and digital entertainment names. @ProsperTradingAcademy's Mike Shorr joins Rick Ducat and Nicole Petallides to break down the technical trends in Eli Lilly (LL
Hims & Hers Health stock tanks after FDA says competitor Eli Lilly's weight-loss drug shortage is over
08:51am, Friday, 04'th Oct 2024
Shares of Hims & Hers Health fell almost 10% today following an announcement from the U.S. Food and Drug Administration (FDA) that competitor Eli Lilly's obesity and diabetes drugs are no longer facin
Eli Lilly to Invest $4.5B for New Manufacturing & Research Plant
04:01pm, Thursday, 03'rd Oct 2024
Lilly is investing $4.5 billion to build a new site for improving manufacturing and drug development.
LLY Outlook Crucial After Mounjaro, Zepbound Shortage Ends
03:49pm, Thursday, 03'rd Oct 2024
Lee Brown with Third Bridge argues that demanding expectations are built into Eli Lilly's (LLY) stock following a "monstrous" 2Q earnings report. Mounjaro and Zepbound no longer on short supply helps
Calls of the Day: Tesla, Eli Lilly and Bank Of America
01:18pm, Thursday, 03'rd Oct 2024
The Investment Committee debate the latest Calls of The Day.
Are Medical Stocks Lagging Eli Lilly (LLY) This Year?
10:47am, Thursday, 03'rd Oct 2024
Here is how Eli Lilly (LLY) and BioLife Solutions, Inc. (BLFS) have performed compared to their sector so far this year.
England's NHS to offer Lilly's weight-loss drugs to some patients
09:05am, Thursday, 03'rd Oct 2024
England's National Health Services plans to offer Eli Lilly's weight-loss drugs to nearly a quarter million people as part of a three-year plan, UK's drugs cost regulator said on Thursday.
Eli Lilly's weight-loss and diabetes drugs are no longer in shortage, says FDA
08:39am, Thursday, 03'rd Oct 2024
The U.S. Food and Drug Administration said Eli Lilly's diabetes and weight-loss drugs marketed as Zepbound and Mounjaro are no longer in shortage signaling that the company has succeeded in expanding
Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers.
08:30am, Thursday, 03'rd Oct 2024
Eli Lilly has gained markedly over the past decade. But it's not the only S&P 500 health care stock to notch a bullish gain.
3 Top Pharma Stocks to Buy in October 2024
08:11am, Thursday, 03'rd Oct 2024
The pharmaceutical industry plays a crucial role in most of our everyday lives.
Eli Lilly's Weight Loss Drugs No Longer In Shortage. It's Bad News for These Stocks.
05:50am, Thursday, 03'rd Oct 2024
Blockbuster drugs Zepbound and Mounjaro have come off the FDA's shortage list.
